221 related articles for article (PubMed ID: 30637599)
1. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer incidence and hormone replacement therapy in Canada.
De P; Neutel CI; Olivotto I; Morrison H
J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
[TBL] [Abstract][Full Text] [Related]
4. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
5. Influence of mammographic screening on breast cancer incidence trends in South Australia.
Beckmann KR; Roder DM; Hiller JE; Farshid G; Lynch JW
Asian Pac J Cancer Prev; 2014; 15(7):3105-12. PubMed ID: 24815455
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
7. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation.
Crocetti E; Buzzoni C; Falcini F; Cortesi L; De Lisi V; Ferretti S; Tumino R; Russo A; Paci E
Breast J; 2010; 16(4):350-5. PubMed ID: 20443789
[TBL] [Abstract][Full Text] [Related]
8. Trends in breast cancer screening in Missouri from 1987 to 1995, and predictions for the years 2000 and 2010.
Sarr M; Simoes EJ; Murayi T; Figgs LT; Brownson RC
Mo Med; 1998 Dec; 95(12):663-9. PubMed ID: 9863343
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
[TBL] [Abstract][Full Text] [Related]
11. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
12. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
Weedon-Fekjær H; Bakken K; Vatten LJ; Tretli S
BMJ; 2012 Jan; 344():e299. PubMed ID: 22290099
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
[TBL] [Abstract][Full Text] [Related]
14. Trends in mammography utilization, 1981 to 1994.
Gaudette LA; Altmayer CA; Nobrega KM; Lee J
Health Rep; 1996; 8(3):17-27(Eng); 19-30(Fre). PubMed ID: 9085118
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the National Breast Screening Programme in Ireland: Two-year interval analysis (2004-2013) of BreastCheck.
Fitzpatrick PE; Greehy G; Mooney MT; Flanagan F; Larke A; Connors A; O'Doherty A
J Med Screen; 2018 Dec; 25(4):191-196. PubMed ID: 29153014
[TBL] [Abstract][Full Text] [Related]
16. Pan-Canadian study of mammography screening and mortality from breast cancer.
Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
[TBL] [Abstract][Full Text] [Related]
17. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
Viel JF; Rymzhanova R; Fournier E; Danzon A
Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
[TBL] [Abstract][Full Text] [Related]
18. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
19. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
[TBL] [Abstract][Full Text] [Related]
20. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
